29.07.2024 17:54:15

EQS-AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Biotest AG / Preliminary announcement on the disclosure of financial statements
Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

29.07.2024 / 17:54 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Biotest AG hereby announces that the following financial reports shall be disclosed for the business year 2024:

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: August 06, 2024
Address: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/quartalsberichte.cfm

Language: English
Date of disclosure: August 06, 2024
Address: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/quarterly_reports.cfm


29.07.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Germany
Internet: www.biotest.de

 
End of News EQS News Service

1956417  29.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1956417&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu Biotest AG Vz.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Biotest AG Vz. 25,90 -4,07% Biotest AG Vz.